Skip to content
CancerIndex

Loading the knowledge graph…

A Study to Evaluate rhuMab 2C4 and Gemcitabine in Subjects With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — knowledge graph · CancerIndex